3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Triple Negative Breast Neoplasms
2
Ovarian Neoplasms
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Nonhematologic Malignancies
2
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Somatostatinoma
1
Sarcoma, Synovial
1
Sarcoma
1
Recurrent Lung Squamous Cell Carcinoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Non-hematologic Malignancy
1
Neurofibrosarcoma
1
Neoplasm Metastasis
1
Metastatic Castration-Resistant Prostate Cancer
1
Meningeal Neoplasms
1
Lymphoma
1
Liver Neoplasms
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hematologic Neoplasms
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Interventions
Leucovorin
38
Fluorouracil
36
Oxaliplatin
34
Bevacizumab
34
Irinotecan
32
Cetuximab
23
Capecitabine
18
Panitumumab
14
IFL protocol
7
Folfox protocol
6
Celecoxib
6
Radiotherapy
5
Nivolumab
5
Magnetic Resonance Spectroscopy
5
Immunohistochemistry
5
Gene Expression Profiling
5
regorafenib
4
pembrolizumab
4
dehydroftorafur
4
Ramucirumab
4
Fluorodeoxyglucose F18
4
Floxuridine
4
aflibercept
3
Surgical Procedures, Operative
3
Sorafenib
3
Radiosurgery
3
Ipilimumab
3
Gemcitabine
3
Fentanyl
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Colonic Neoplasms
×
sapanisertib
×
Clear all
No trials found.